Wimmer Associates 1, LLC Abb Vie Inc. Transaction History

Wimmer Associates 1, LLC

  • $201 Million
  • Q3 2024

A detailed history of Wimmer Associates 1, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 15,353 shares of ABBV stock, worth $2.75 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares
15,353
Previous 15,397 0.29%
Holding current value
$2.75 Million
Previous $2.64 Million 14.81%
% of portfolio
1.51%
Previous 1.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$163.84 - $199.33 $7,208 - $8,770
-44 Reduced 0.29%
15,353 $3.03 Million
Q1 2024

May 14, 2024
SELL
$159.82 - $182.1 $202,172 - $230,356
-1,265 Reduced 7.59%
15,397 $2.8 Million
Q4 2023

Feb 14, 2024
BUY
$137.6 - $154.97 $27,520 - $30,994
200 Added 1.21%
16,662 $2.58 Million
Q3 2023

Nov 14, 2023
SELL
$133.59 - $154.65 $5,210 - $6,031
-39 Reduced 0.24%
16,462 $2.45 Million
Q2 2023

Aug 14, 2023
SELL
$132.51 - $164.9 $6,625 - $8,245
-50 Reduced 0.3%
16,501 $2.22 Million
Q1 2023

May 16, 2023
SELL
$144.61 - $166.54 $61,603 - $70,946
-426 Reduced 2.51%
16,551 $2.64 Million
Q4 2022

Feb 14, 2023
SELL
$138.31 - $165.87 $1,659 - $1,990
-12 Reduced 0.07%
16,977 $2.75 Million
Q3 2022

Nov 14, 2022
SELL
$134.21 - $153.93 $14,360 - $16,470
-107 Reduced 0.63%
16,989 $2.49 Million
Q2 2022

Aug 12, 2022
SELL
$137.62 - $174.96 $22,982 - $29,218
-167 Reduced 0.97%
17,096 $2.62 Million
Q1 2022

May 13, 2022
BUY
$131.98 - $163.75 $52,791 - $65,500
400 Added 2.37%
17,263 $2.8 Million
Q4 2021

Feb 16, 2022
BUY
$107.43 - $135.93 $29,328 - $37,108
273 Added 1.65%
16,863 $2.28 Million
Q3 2021

Nov 12, 2021
BUY
$106.4 - $120.78 $4,362 - $4,951
41 Added 0.25%
16,590 $1.79 Million
Q2 2021

Aug 12, 2021
BUY
$105.21 - $117.21 $3,577 - $3,985
34 Added 0.21%
16,549 $1.86 Million
Q1 2021

May 14, 2021
SELL
$102.3 - $112.62 $19,641 - $21,623
-192 Reduced 1.15%
16,515 $1.79 Million
Q4 2020

Feb 16, 2021
SELL
$80.49 - $108.67 $8,612 - $11,627
-107 Reduced 0.64%
16,707 $1.79 Million
Q3 2020

Dec 03, 2020
BUY
$85.91 - $100.83 $81,356 - $95,486
947 Added 5.97%
16,814 $1.47 Million
Q2 2020

Aug 14, 2020
SELL
$73.37 - $98.18 $79,679 - $106,623
-1,086 Reduced 6.41%
15,867 $1.47 Million
Q1 2020

May 15, 2020
BUY
$64.5 - $97.79 $88,171 - $133,678
1,367 Added 8.77%
16,953 $1.29 Million
Q4 2019

Feb 13, 2020
BUY
$72.13 - $90.25 $15,507 - $19,403
215 Added 1.4%
15,586 $1.38 Million
Q3 2019

Nov 14, 2019
SELL
$62.98 - $75.72 $4,723 - $5,679
-75 Reduced 0.49%
15,371 $1.16 Million
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $7,029 - $8,985
107 Added 0.7%
15,446 $1.12 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $9,256 - $10,894
-120 Reduced 0.78%
15,339 $1.24 Million
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $72,556 - $89,481
-932 Reduced 5.69%
15,459 $1.43 Million
Q3 2018

Nov 13, 2018
SELL
$88.91 - $98.84 $171,151 - $190,267
-1,925 Reduced 10.51%
16,391 $1.55 Million
Q2 2018

Aug 14, 2018
BUY
$89.78 - $106.23 $5,297 - $6,267
59 Added 0.32%
18,316 $1.7 Million
Q1 2018

May 10, 2018
BUY
$92.01 - $123.21 $9,385 - $12,567
102 Added 0.56%
18,257 $1.73 Million
Q4 2017

Feb 14, 2018
SELL
$89.56 - $98.21 $32,958 - $36,141
-368 Reduced 1.99%
18,155 $1.76 Million
Q3 2017

Nov 14, 2017
SELL
$69.85 - $89.22 $76,625 - $97,874
-1,097 Reduced 5.59%
18,523 $1.65 Million
Q2 2017

Aug 14, 2017
BUY
N/A
19,620
19,620 $1.42 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email